Security Snapshot

ADARx Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share Institutional Ownership

CUSIP: 00654F105

13F Institutional Holders and Ownership History

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
106,845,817

Key facts

  • 00654F105 - ADARx Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 00654F105.
  • Latest finished 13F holder period is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Quarterly ownership records are not available yet for this CUSIP.
  • This page updates as SEC-backed holdings history becomes available.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

00654F105

Latest holder period

n/a

13F holders

13D/G owners

3

CIK / CUSIP context first

00654F105 full holder history ADARx Pharmaceuticals, Inc. SEC filings ADARx Pharmaceuticals, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
00654F105
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORBIMED ADVISORS LLC 14% 14,913,764 ORBIMED ADVISORS LLC 28 Sep 2026
SR ONE CAPITAL MANAGEMENT, LLC 9.3% 9,936,661 SR One Capital Management, LLC 28 Sep 2026
BCLS Fund III Investments, LP 6.3% 6,728,970 BCLS Fund III Investments, LP 24 Sep 2026
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .